Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency

Journal of Virology

Volumn 72, Issue 10, 1998, Pages 7796-7806

  Fruehling, Sara ^a   Swart, Rachel ^a   Dolwick, Kristine M ^a   Kremmer, Elisabeth ^b   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LATENT PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 0031661310     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.10.7796-7806.1998     Document Type: Article

References (48)

1. Bolen, J. B. 1993. Nonreceptor tyrosine protein kinases. Oncogene 8:2025-2031.
2. Burkhardt, A. L., J. B. Bolen, E. Kieff, and R. Longnecker. 1992. An Epstein-Barr virus transformation-associated membrane protein interacts with Src family tyrosine kinases. J. Virol. 66:5161-5167.
3. Burkhardt, A. L., M. Brunswick, J. B. Bolen, and J. J. Mond. 1991. Antiimmunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA 88:7410-7414.
4. Cambier, J. C. 1995. New nomenclature for the Reth motif (or ARH1/TAM/ ARAM/YXXL). Immunol. Today 16:110.
5. Cambier. J. C., C. M. Pleiman, and M. R. Clark. 1994. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12: 457-486.
6. Campbell, M. A., and B. M. Sefton. 1992. Association between B-lymphocyte membrane immunoglobulin and multiple members of the Src family of protein tyrosine kinases. Mol. Cell. Biol. 12:2315-2321.
7. Cheng, A. M., B. Rowley, W. Pao, A. Hayday, J. B. Bolen, and T. Pawson. 1995. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378:303-306.
8. Clark, M. R., S. A. Johnson, and J. C. Cambier. 1994. Analysis of Ig-alpha-tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig-alpha stimulation of Fyn activity. EMBO J. 13: 1911-1919.
9. D'Ambrosio, D., K. L. Hippen, S. A. Minskoff, I. Mellman, G. Pani, K. A. Siminovitch, and J. C. Cambier. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcgRIIB1. Science 268:293-297.
10. DeFranco, A. L. 1995. Transmembrane signaling by antigen receptors of B and T lymphocytes. Curr. Opin. Cell Biol. 7:163-175.
11. Fruehling, S., S. Lee, R. Herrold, B. Frech, G. Laux, E. Kremmer, F. A. Grässer, and R. Longnecker. 1996. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J. Virol. 70:6216-6226.
12. Fruehling, S., and R. Longnecker, 1997. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mcdiated signal transduction. Virology 235:241-251.
13. Gold, M. R., and L. Matsuuchi. 1995. Signal transduction by the antigen receptors of B and T lymphocytes. Int. Rev. Cytol. 157:181-276.
14. Heston, L., M. Rabson, N. Brown, and G. Miller. 1982. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature 295:160-163.
15. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995, Multiple defects in the immune system of lyn-deficient mice, culminating in autoimmune disease. Cell 83:301-311.
16. Hutchcroft, J. E., M. L. Harrison, and R. L. Geahlen. 1992. Association of the 72-kDa protein-tyrosine kinase PTK72 with the B cell antigen receptor. J. Biol. Chem. 267:8613-8619.
17. syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides. Mol. Cell. Biol. 16:1471-1478.
18. Lee, S. K., and P. H. Stern. 1994. Studies on the mechanism of desensitization of the parathyroid hormone-stimulated calcium signal in UMR-106 cells: reversal of desensitization by alkaline phosphatase but not by protein kinase C downregulation. J. Bone Miner. Res. 9:781-789.
19. Lin, J., and L. B. Justement. 1992. The MB-1/B29 heterodimer couples the B cell antigen receptor to multiple src family protein tyrosine kinases. J. Immunol. 149:1548-1555.
20. Longnecker, R., B. Druker, T. M. Roberts, and E. Kieff. 1991. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J. Virol. 65:3681-3692.
21. Longnecker, R., and E. Kieff. 1990. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J. Virol. 64:2319-2326.
22. Longnecker, R., C. L. Miller, X.-Q. Miao, A. Marchini, and E. Kieff. 1992. The only domain which distinguishes Epstein-Barr virus latent membrane 2A (LMP2A) from LMP2B is dispensible for lymphocyte infection and growth transformation in vitro, and LMP2A is therefore nonessential. J. Virol. 66:6461-6469.
23. Marchini, A., B. Tomkinson. J. I. Cohen, and E. Kieff. 1991. BHRF1, the Epstein-Barr virus gene with homology to Bcl2. is dispensable for B-lymphocyte transformation and virus replication. J. Virol. 65:5991-6000.
24. Menezes, J., W. Leibold, G. Klein, and G. Clements. 1975. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional. EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22:276-284.
25. Merrit, J. E., S. A. McCarthy, M. P. A. Davies, and K. E. Moores. 1990. Use of fluo-3 to measure cytosolic Ca2+ in platelets and neutrophils. Biochem. J. 269:513-519.
26. Miller, C. L., A. L. Burkhardt, J. H. Lee, B. Stealey, R. Longnecker, J. B. Bolen, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166.
27. Miller, C. L., J. H. Lee, E. Kieff, and R. Longnecker. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad Sci USA 91:772-776.
28. Miller, C. L., R. Longnecker, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67:3087-3094.
29. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70:190-194
30. Miller, G., T. Shope, H. Lisco, D. Stitt, and M. Lipman. 1972. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc. Natl. Acad. Sci. USA 69:383-387.
31. Munger, K., B. A. Werness, N. Dyson, W. C. Phelps, E. Harlem, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099-4105.
32. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549-560.
33. Panousis, C. G., and D. T. Rowe. 1997. Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J. Virol. 71:4752-4760.
34. Pawson, T., and G. D. Gish. 1992. SH2 and SH3 domains: from structure to function. Cell 71:359-362.
35. Pleiman, C. M., C. Abrams, L. T. Gauen, W. Bedzyk, J. Jongstra, A. S. Shaw, and J. C. Cambier. 1994. Distinct p53/561yn and p59fyn domains, associate with nonphosphorylated and phosphorylated Ig-alpha. Proc. Natl. Acad. Sci. USA 91:4268-4272.
36. Pleiman, C. M., D. D'Ambrosio, and J. C. Cambier. 1994. The B-cell antigen receptor complex: structure and signal transduction. Immunol. Today 15: 393-399.
37. Reth, M. 1989. Anligen receptor tail clue. Nature 338:383-384.
38. Schaffhausen, B. 1995. SH2 domain structure and function. Biochim. Biophys. Acta 1242:61-75.
39. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts. S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
40. Swaminathan, S., B. Torakinson, and E. Kieff. 1991. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc. Natl. Acad. Sci. USA 88:1546-1550.
41. Takata, M., H. Sabe, A. Hata, T. Inazu, Y. Homma, T. Nukada, H. Yamamura, and T. Kurosaki. 1994. Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J. 13:1341-1349.
42. Turner, M., P. J. Mee, P. S. Costello, O. Williams, A. A. Price, L. P. Duddy, M. T. Furlong, R. L. Geahlen, and V. L. J. Tybulewicz. 1995. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378:298-302.
43. Wang, F., A. Marchini, and E. Kieff. 1991. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells. J. Virol. 65:1701-1709.
44. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263-274.
45. Yamada, T., T. Tanaguchi, C. Yang, S. Yasue, H. Saito, and H. Yamamura. 1993. Association with B-cell-antigen receptor with protein-tyrosine kinase p72syk and activation by engagement of membrane IgM. Eur. J. Biochem. 213:455.
46. Yamanashi, Y., Y. Fukui. W. Wongsasant, Y. Kinoshita, Y. Ichimori, K. Toyoshima, and T. Yamamoto. 1992. Activation of src-like protein-tyrosine kinase lyn and its association with PI(3)kinase upon B-cell antigen receptor-mediated signalling. Proc. Natl. Acad. Sci. USA 89:1118-1122.
47. Yi. T. L., J. B. Bolen, and J. N. Ihle. 1991. Hematopoietic cells express two forms of Lyn kinase differine by 21 amino acids in the amino terminus. Mol. Cell. Biol. 11:2391-2398.
48. Young, L. S., R. Lau, M. Rowe, G. Niedobitek, G. Packham, F. Shanahan, D. T. Rowe, D. Greenspan, J. S. Greenspan, A. B. Rickinson. and P. J. Farrell. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:2868-2874.